Výsledky vyhľadávania - "Asparaginase administration & dosage"

Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia

Autori: Thomas Frandsen Kjeld Schmiegelow Bendik Lund a ďalší

Prispievatelia: Thomas Frandsen Kjeld Schmiegelow Bendik Lund a ďalší

Zdroj: Gottschalk Højfeldt, S, Grell, K, Abrahamsson, J, Lund, B, Vettenranta, K, Jonsson, O G, Frandsen, T L, Wolthers, B O, Marquart, H V H, Vaitkeviciene, G, Lepik, K, Heyman, M, Schmiegelow, K & Albertsen, B K 2021, ' Relapse risk following truncation of PEG-asparaginase in childhood acute lymphoblastic leukemia ', Blood, vol. 137, no. 17, pp. 2373–2382 . https://doi.org/10.1182/blood.2020006583
Gottschalk Højfeldt, S, Grell, K, Abrahamsson, J, Lund, B, Vettenranta, K, Jonsson, O G, Frandsen, T L, Wolthers, B O, Marquart, H V H, Vaitkeviciene, G, Lepik, K, Heyman, M, Schmiegelow, K, Albertsen, B K & Nordic Society of Pediatric Hematology and Oncology, NOPHO Group 2021, 'Relapse risk following truncation of pegylated asparaginase in childhood acute lymphoblastic leukemia', Blood, vol. 137, no. 17, pp. 2373-2382. https://doi.org/10.1182/blood.2020006583

Predmety: Male, Adolescent, Netherlands/epidemiology, CHILDREN, Antineoplastic Agents, Polyethylene Glycols, 03 medical and health sciences, 0302 clinical medicine, Risk Factors, Asparaginase, Humans, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Prospective Studies, Polyethylene Glycols/administration & dosage, Child, Netherlands, Neoplasm Recurrence, Local/epidemiology, Leukemia, Dose-Response Relationship, Drug, INDUCTION, Incidence, PANCREATITIS, Infant, Asparaginase/administration & dosage, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Prognosis, General medicine, internal medicine and other clinical medicine, Antineoplastic Agents/administration & dosage, 3. Good health, Survival Rate, Child, Preschool, Female, Neoplasm Recurrence, Local, Follow-Up Studies

Popis súboru: application/pdf

Prístupová URL adresa: https://helda.helsinki.fi/bitstream/10138/336002/1/Relapse_risk_following_truncation_of_PEG_asparaginase.pdf
https://pubmed.ncbi.nlm.nih.gov/33150360
https://helda.helsinki.fi/handle/10138/336002
https://pubmed.ncbi.nlm.nih.gov/33150360/
http://www.sciencedirect.com/science/article/pii/S0006497121009204
https://researchportal.helsinki.fi/fi/publications/relapse-risk-following-truncation-of-peg-asparaginase-in-childhoo
https://www.ncbi.nlm.nih.gov/pubmed/33150360
https://www.sciencedirect.com/science/article/pii/S0006497121009204
http://hdl.handle.net/10138/336002
https://curis.ku.dk/ws/files/322568862/relapse_risk_following_2_26.pdf
http://www.scopus.com/inward/record.url?scp=85105617052&partnerID=8YFLogxK
https://doi.org/10.1182/blood.2020006583
https://pure.au.dk/portal/en/publications/cdbd1b64-7fd2-4a85-b2a5-39d7129dc27e

Efficacy of L-asparaginase with methotrexate and dexamethasone (AspaMetDex regimen) in patients with refractory or relapsing extranodal NK/T-cell lymphoma, a phase 2 study.

Autori: Jaccard, A. Gachard, N. Marin, B. a ďalší

Prispievatelia: Jaccard, A. Gachard, N. Marin, B. a ďalší

Predmety: Aged, Antibodies/blood, Antineoplastic Combined Chemotherapy Protocols/therapeutic use, Asparaginase/administration & dosage, Asparaginase/immunology, DNA, Viral/blood, Dexamethasone/administration & dosage, Disease-Free Survival, Female, France, Herpesvirus 4, Human/isolation & purification, Humans, Kaplan-Meier Estimate, Lymphoma, Extranodal NK-T-Cell/drug therapy, Extranodal NK-T-Cell/immunology, Male, Methotrexate/administration & dosage, Middle Aged, Prognosis, Prospective Studies, Recurrence, Remission Induction, Salvage Therapy

Relation: Blood; https://iris.unil.ch/handle/iris/95562; serval:BIB_2A17F8675253; 000287192300018

Dostupnosť: https://iris.unil.ch/handle/iris/95562
https://doi.org/10.1182/blood-2010-09-307454

Epigenetic Silencing Affectsl-Asparaginase Sensitivity and Predicts Outcome in T-ALL

Autori: Touzart, Aurore Lengliné, Etienne Latiri, Mehdi a ďalší

Prispievatelia: Touzart, Aurore Lengliné, Etienne Latiri, Mehdi a ďalší

Zdroj: Clinical Cancer Research, Vol. 25, No 8 (2019) pp. 2483-2493
Clinical cancer research, Vol. 25, no. 8, p. 2483-2493 (2019)

Predmety: Adult, Male, 0301 basic medicine, Adolescent, [SDV]Life Sciences [q-bio], Antineoplastic Agents/administration & dosage/adverse effects/pharmacology, [SDV.CAN]Life Sciences [q-bio]/Cancer, Drug Resistance, Neoplasm/genetics, Antineoplastic Agents, Kaplan-Meier Estimate, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma, Epigenesis, Genetic, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy/genetics/mortality/pathology, Young Adult, 03 medical and health sciences, [SDV.CAN] Life Sciences [q-bio]/Cancer, Asparaginase/administration & dosage/adverse effects/pharmacology, Cell Line, Tumor, Asparaginase, Humans, Gene Silencing, Promoter Regions, Genetic, ddc:616, 0303 health sciences, Gene Expression Profiling, Age Factors, DNA Methylation, Middle Aged, Prognosis, 3. Good health, [SDV] Life Sciences [q-bio], Gene Expression Regulation, Neoplastic, [SDV.IMM.IA]Life Sciences [q-bio]/Immunology/Adaptive immunology, Drug Resistance, Neoplasm, [SDV.IMM.IA] Life Sciences [q-bio]/Immunology/Adaptive immunology, Female, Transcriptome

Popis súboru: application/pdf

Prístupová URL adresa: https://clincancerres.aacrjournals.org/content/25/8/2483.full-text.pdf
https://pubmed.ncbi.nlm.nih.gov/30659025
https://pubmed.ncbi.nlm.nih.gov/30659025/
https://clincancerres.aacrjournals.org/content/25/8/2483
https://hal-amu.archives-ouvertes.fr/hal-02078351/document
http://clincancerres.aacrjournals.org/content/early/2019/02/19/1078-0432.CCR-18-1844
https://archive-ouverte.unige.ch/unige:144872
https://clincancerres.aacrjournals.org/content/clincanres/early/2019/01/18/1078-0432.CCR-18-1844.full.pdf
https://amu.hal.science/hal-02078351v1/document
https://amu.hal.science/hal-02078351v1
https://doi.org/10.1158/1078-0432.ccr-18-1844
https://archive-ouverte.unige.ch/unige:144872
https://archive-ouverte.unige.ch/unige:144872
https://doi.org/10.1158/1078-0432.ccr-18-1844
https://hdl.handle.net/2078.1/212348

Concurrent chemoradiotherapy followed by l-asparaginase-containing chemotherapy, VIDL, for localized nasal extranodal NK/T cell lymphoma: CISL08-01 phase II study

Autori: Jong Ho Won Sang-wook Lee Won Seog Kim a ďalší

Prispievatelia: Jong Ho Won Sang-wook Lee Won Seog Kim a ďalší

Zdroj: Annals of Hematology. 93:1895-1901

Predmety: Adult, Male, 0301 basic medicine, Extranodal NK-T-Cell/diagnosis, Lymphoma, Chemoradiotherapy/methods, Drug Administration Schedule, Young Adult, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Chemotherapy, Asparaginase, Humans, Aged, 2. Zero hunger, Survival Rate/trends, Antineoplastic Combined Chemotherapy Protocols/administration & dosage, Asparaginase/administration & dosage, Radiotherapy, Chemoradiotherapy, Middle Aged, Extranodal NK-T-Cell/drug therapy, 3. Good health, Lymphoma, Extranodal NK-T-Cell, Survival Rate, l-Asparaginase, Extranodal NK-T-Cell/radiotherapy, Extranodal NK/T cell lymphoma, Female

Popis súboru: 1895~1901

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/24947798
https://link.springer.com/article/10.1007/s00277-014-2137-6/fulltext.html
https://www.ncbi.nlm.nih.gov/pubmed/24947798
https://link.springer.com/article/10.1007/s00277-014-2137-6
https://mdanderson.elsevierpure.com/en/publications/concurrent-chemoradiotherapy-followed-by-l-asparaginase-containin
https://europepmc.org/article/MED/24947798
https://yonsei.pure.elsevier.com/en/publications/concurrent-chemoradiotherapy-followed-by-l-asparaginase-containin

Phase II Study of SMILE Chemotherapy for Newly Diagnosed Stage IV, Relapsed, or Refractory Extranodal Natural Killer (NK)/T-Cell Lymphoma, Nasal Type: The NK-Cell Tumor Study Group Study

Autori: Chizuko Hashimoto Takao Kodama Rie Hyo a ďalší

Zdroj: Journal of Clinical Oncology. 29:4410-4416

Predmety: Adult, Male, 0301 basic medicine, Lymphoma, Adolescent, Nose Neoplasms, Antineoplastic Combined Chemotherapy Protocols - Adverse Effects - Therapeutic Use, Lymphoma, Extranodal Nk-T-Cell - Drug Therapy - Mortality - Pathology, Extranodal Nk-T-Cell - Drug Therapy - Mortality - Pathology, Middle Aged, 3. Good health, Lymphoma, Extranodal NK-T-Cell, Asparaginase - Administration & Dosage, 03 medical and health sciences, 0302 clinical medicine, Recurrence, Antineoplastic Combined Chemotherapy Protocols, Nose Neoplasms - Drug Therapy - Pathology, Asparaginase, Humans, Female, Aged, Neoplasm Staging

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/21990393
https://okayama.pure.elsevier.com/en/publications/phase-ii-study-of-smile-chemotherapy-for-newly-diagnosed-stage-iv
https://ascopubs.org/doi/pdfdirect/10.1200/JCO.2011.35.6287
https://jglobal.jst.go.jp/detail?JGLOBAL_ID=201202265165279205
https://doi.org/10.1200%2fJCO.2011.35.6287
https://www.ncbi.nlm.nih.gov/pubmed/21990393
https://europepmc.org/article/MED/21990393
http://hdl.handle.net/10722/163418

Diagnosis and management of natural killer-cell malignancies

Autori: Kwong, YL Ishida, F

Zdroj: Expert Review of Hematology. 3:593-602

Predmety: Male, Herpesvirus 4, Human, Asia - Epidemiology, Asia, Lymphoma, Severity of Illness Index, Transplantation, Autologous, Cd, 03 medical and health sciences, 0302 clinical medicine, Antigens, CD, Recurrence, Leukemia - Diagnosis - Mortality - Pathology - Therapy, Antineoplastic Combined Chemotherapy Protocols, Killer Cells, Asparaginase, Humans, Antigens, Transplantation, Lymphoma, Extranodal Nk-T-Cell - Diagnosis - Mortality - Pathology - Therapy, Leukemia, Herpesvirus 4, South America - Epidemiology, Hematopoietic Stem Cell Transplantation, Asparaginase - Administration & Dosage - Therapeutic Use, Antineoplastic Combined Chemotherapy Protocols - Administration & Dosage - Therapeutic Use, Middle Aged, South America, Prognosis, 3. Good health, Killer Cells, Natural, Lymphoma, Extranodal NK-T-Cell, Severity Of Illness Index, Antigens, Cd, Female, Autologous, Human, Natural - Drug Effects - Pathology, Extranodal Nk-T-Cell - Diagnosis - Mortality - Pathology - Therapy, Killer Cells, Natural - Drug Effects - Pathology

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/21083476
https://www.tandfonline.com/doi/full/10.1586/ehm.10.51
https://www.ncbi.nlm.nih.gov/pubmed/21083476
https://europepmc.org/article/MED/21083476
http://hub.hku.hk/handle/10722/163342
https://pubmed.ncbi.nlm.nih.gov/21083476/
https://core.ac.uk/display/37984663
http://hdl.handle.net/10722/163342

Testicular function after treatment for lymphoblastic leukemia (all) in prepubertal and pubertal boys

Autori: Solarz, Elżbieta Wysocka, Jolanta Matysiak, Michał a ďalší

Zdroj: Pediatric Hematology and Oncology. 26(7):504-514

Predmety: Male, Adolescent, Vincristine - administration & dosage, Daunorubicin - adverse effects, Spermatogenesis - drug effects, Vincristine - adverse effects, Antineoplastic combined chemotherapy protocols - administration & dosage, preschool, Asparaginase - adverse effects, Asparaginase - administration & dosage, Luteinizing hormone - blood, Precursor cell lymphoblastic leukemia-lymphoma - drug therapy, Testis - growth & development, Daunorubicin - administration & dosage, Humans, Child, Precursor cell lymphoblastic leukemia-lymphoma - pathology, Precursor cell lymphoblastic leukemia-lymphoma - blood, Testis - pathology, Retrospective studies, Antineoplastic combined chemotherapy protocols - adverse effects, Testis - metabolism, Prednisone - administration & dosage, Inhibins - blood, Prednisone - adverse effects, Testosterone - blood, Follicle stimulating hormone - blood

Phase I study of dexamethasone, methotrexate, ifosfamide, l‐asparaginase, and etoposide (SMILE) chemotherapy for advanced‐stage, relapsed or refractory extranodal natural killer (NK)/T‐cell lymphoma and leukemia

Autori: Oshimi, K Yamaguchi, M Suzuki, R a ďalší

Zdroj: Cancer Science. 99:1016-1020

Predmety: Extranodal NK-T-Cell - drug therapy - prevention & control, Adult, Lymphoma, Lymphoma, Extranodal NK-T-Cell - drug therapy - prevention & control, Adolescent, Etoposide - administration & dosage - therapeutic use, Leukemia, Lymphoid - drug therapy - prevention & control, Dexamethasone, Antineoplastic Combined Chemotherapy Protocols - administration & dosage - therapeutic use, 03 medical and health sciences, 0302 clinical medicine, Methotrexate - administration & dosage - therapeutic use, Recurrence, Antineoplastic Combined Chemotherapy Protocols, Asparaginase - administration & dosage - therapeutic use, Asparaginase, Humans, Ifosfamide, Aged, Etoposide, Leukemia, Lymphoid - drug therapy - prevention & control, Middle Aged, Leukemia, Lymphoid, 3. Good health, Lymphoma, Extranodal NK-T-Cell, Methotrexate, Ifosfamide - administration & dosage - therapeutic use, Dexamethasone - administration & dosage - therapeutic use

Prístupová URL adresa: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1349-7006.2008.00768.x
https://pubmed.ncbi.nlm.nih.gov/18294294
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1349-7006.2008.00768.x
https://core.ac.uk/display/37908458
https://pubmed.ncbi.nlm.nih.gov/18294294/
https://ci.nii.ac.jp/naid/10024006386
https://onlinelibrary.wiley.com/doi/10.1111/j.1349-7006.2008.00768.x
http://hdl.handle.net/10722/77437

Improved treatment outcome in adult acute lymphoblastic leukemia using the intensive German protocol, a preliminary report

Autori: Chim, CS Kwong, YL Chu, YC a ďalší

Zdroj: Hematological Oncology. 15:19-26

Predmety: Adult, Male, Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy, Adolescent, Antineoplastic Combined Chemotherapy Protocols - Adverse Effects - Therapeutic Use, Asparaginase - Administration & Dosage - Adverse Effects, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma, 3. Good health, 03 medical and health sciences, 0302 clinical medicine, Treatment Outcome, Antineoplastic Combined Chemotherapy Protocols, Asparaginase, Humans, Female

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/9378468
https://onlinelibrary.wiley.com/doi/10.1002/%28SICI%291099-1069%28199702%2915%3A1%3C19%3A%3AAID-HON591%3E3.0.CO%3B2-G
http://hub.hku.hk/handle/10722/162189
http://europepmc.org/abstract/MED/9378468
http://www.ncbi.nlm.nih.gov/pubmed/9378468
http://hdl.handle.net/10722/162189

Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites

Autori: Päivi M. Lähteenmäki Stine Nygaard Nielsen Birgitte Klug Albertsen a ďalší

Zdroj: Toksvang, L N, De Pietri, S, Nielsen, S N, Nersting, J, Albertsen, B K, Wehner, P S, Rosthøj, S, Lähteenmäki, P M, Nilsson, D, Nystad, T A, Grell, K, Frandsen, T L & Schmiegelow, K 2017, 'Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites', Pediatric Blood & Cancer, vol. 64, no. 9, e26519. https://doi.org/10.1002/pbc.26519
Toksvang, L N, De Pietri, S, Nielsen, S N, Nersting, J, Albertsen, B K, Wehner, P S, Rosthøj, S, Lähteenmäki, P M, Nilsson, D, Nystad, T A, Grell, K, Frandsen, T L & Schmiegelow, K 2017, ' Hepatic sinusoidal obstruction syndrome during maintenance therapy of childhood acute lymphoblastic leukemia is associated with continuous asparaginase therapy and mercaptopurine metabolites ', Pediatric Blood & Cancer, vol. 64, no. 9, e26519 . https://doi.org/10.1002/pbc.26519

Predmety: Male, 0301 basic medicine, Adolescent, Liver toxicity, Hepatic Veno-Occlusive Disease, Kaplan-Meier Estimate, Acute lymphoblastic leukemia, Mercaptopurine/administration & dosage, Maintenance Chemotherapy, Polyethylene Glycols, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Journal Article, Asparaginase, Humans, Precursor Cell Lymphoblastic Leukemia-Lymphoma/drug therapy, Drug Interactions, Preschool, Polyethylene Glycols/administration & dosage, Child, Methotrexate/administration & dosage, Proportional Hazards Models, Sinusoidal obstruction syndrome, Mercaptopurine, Antineoplastic Combined Chemotherapy Protocols/adverse effects, Infant, Asparaginase/administration & dosage, Precursor Cell Lymphoblastic Leukemia-Lymphoma, ta3122, Clinical Trial, ta3123, 3. Good health, Methotrexate, Hepatic Veno-Occlusive Disease/chemically induced, Child, Preschool, Female, Maintenance therapy

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/28423235
http://juuli.fi/Record/0286115917
http://juuli.fi/Record/0281917917
https://doi.org/10.1002/pbc.26519
https://vbn.aau.dk/da/publications/cd387074-4243-4499-87cc-3fa54daf1fd7
https://doi.org/10.1002/pbc.26519
https://www.ncbi.nlm.nih.gov/pubmed/28423235
https://onlinelibrary.wiley.com/doi/10.1002/pbc.26519
https://europepmc.org/article/MED/28423235
https://vbn.aau.dk/en/publications/hepatic-sinusoidal-obstruction-syndrome-during-maintenance-therap
https://core.ac.uk/display/84876239
https://pubmed.ncbi.nlm.nih.gov/28423235/
https://portal.findresearcher.sdu.dk/da/publications/e58f451a-91b6-442d-8dd6-01754428b07b
http://www.scopus.com/inward/record.url?scp=85018573879&partnerID=8YFLogxK
https://doi.org/10.1002/pbc.26519
https://pure.au.dk/portal/en/publications/03907791-ee86-4d04-88a5-0ad4c8154700

Epigenetic Silencing Affects l-Asparaginase Sensitivity and Predicts Outcome in T-ALL

Autori: Touzart, Aurore Lengliné, Etienne Latiri, Mehdi a ďalší

Zdroj: ISSN: 1078-0432 ; Clinical Cancer Research, vol. 25, no. 8 (2019) p. 2483-2493.

Predmety: info:eu-repo/classification/ddc/616, Adolescent, Adult, Age Factors, Antineoplastic Agents/administration & dosage/adverse effects/pharmacology, Asparaginase/administration & dosage/adverse effects/pharmacology, Cell Line, Tumor, DNA Methylation, Drug Resistance, Neoplasm/genetics, Epigenesis, Genetic, Female, Gene Expression Profiling, Gene Expression Regulation, Neoplastic, Gene Silencing, Humans, Kaplan-Meier Estimate, Male, Middle Aged, Precursor T-Cell Lymphoblastic Leukemia-Lymphoma/drug therapy/genetics/mortality/pathology, Prognosis, Promoter Regions, Transcriptome, Young Adult

Relation: info:eu-repo/semantics/altIdentifier/pmid/30659025; unige:144872

Dostupnosť: https://archive-ouverte.unige.ch/unige:144872

Poor outcome of intensive chemotherapy for adult acute lymphoblastic leukemia: a possible dose effect

Autori: Chan, LC Kwong, YL Liang, R a ďalší

Zdroj: Leukemia. 8(9)

Predmety: Adult, Male, 6-Mercaptopurine - Administration & Dosage, Leucovorin, Daunorubicin - Administration & Dosage, Leucovorin - Administration & Dosage, Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use, Vincristine - Administration & Dosage, Recurrence, Antineoplastic Combined Chemotherapy Protocols, Asparaginase, Humans, Cyclophosphamide - Administration & Dosage, Cyclophosphamide, Aged, Retrospective Studies, Cytarabine - Administration & Dosage, Mercaptopurine, Daunorubicin, Remission Induction, Cytarabine, Middle Aged, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Prognosis, Teniposide - Administration & Dosage, Survival Rate, Prednisone - Administration & Dosage, Asparaginase - Administration & Dosage, Methotrexate, Methotrexate - Administration & Dosage, Precursor Cell Lymphoblastic Leukemia-Lymphoma - Drug Therapy - Mortality, Prednisone, Female

Prístupová URL adresa: https://pubmed.ncbi.nlm.nih.gov/8090027
http://hdl.handle.net/10722/148010